The relationship between plasma lipids, oxidant–antioxidant status, and glycated proteins in individuals at risk for atherosclerosis

References

• Romano AD, Serviddio G, de Matthaeis A, Bellanti F, Vendemiale G. Oxidative stress and aging. J Nephrol. 2010;23(Suppl 15):S29–S36.20872368
   PubMedGoogle Scholar
• Gautieri A, Passini FS, Silván U, et al. Advanced glycation end-products: mechanics of aged collagen from molecule to tissue. Matrix Biol. 2016: pii: S0945-053X(16)30168-8. doi:10.1016/j.matbio.2016.09.001.
   Web of Science ®Google Scholar
• Cesari M, Kritchevsky SB, Nicklas B, of Health ABC study, et al. Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. J Gerontol A Biol Sci Med Sci. 67;2012:671–676. doi:10.1093/gerona/glr246.22389462
   PubMed Web of Science ®Google Scholar
• Radman M. Protein damage, radiation sensitivity and aging. DNA Repair (Amst). 2016;44:186–192. doi:10.1016/j.dnarep.2016.05.02527264559
   PubMed Web of Science ®Google Scholar
• Kanu N, Penicud K, Hristova M, et al. The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain. J Biol Chem. 2010;285:38534–38542. doi:10.1074/jbc.M110.14589620889973
   PubMed Web of Science ®Google Scholar
• Rb D Sr, Rs V, Mj P, Pa W, Cobain M, Jm M. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–753. doi:10.1161/CIRCULATIONAHA.107.69957918212285
   PubMed Web of Science ®Google Scholar
• Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002;105:310–315. doi:10.1161/hc0302.10257511804985
   PubMed Web of Science ®Google Scholar
• Conroy RM, Pyorala K, Fitzgerald AP, on behalf of the SCORE project group, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur H J. 24;2003:987–1003. doi:10.1016/S0195-668X(03)00114-3.
   PubMed Web of Science ®Google Scholar
• Martin-Ventura JL, Rodrigues-Diez R, Martinez-Lopez D, Salaices M, Blanco-Colio LM, Briones AM. Oxidative stress in human atherothrombosis: sources, markers and therapeutic targets. Int J Mol Sci. 2017;18(11):2315. doi:10.3390/ijms18112315
   Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497. doi:10.1001/jama.285.19.2486.11368702
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002;288(23):2998–3007.12479764
   PubMed Web of Science ®Google Scholar
• Shepherd J, Blauw GJ, Murphy MB, et al.; the PROSPER Study Group. PROspective study of pravastatin in the elderly at risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–1630.12457784
   PubMed Web of Science ®Google Scholar
• Bruckert E, Lièvre M, Giral P, et al. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients. Am J Geriatr Cardiol. 2003;12:225–231. doi:10.1111/j.1076-7460.2003.02000.x12888702
   PubMedGoogle Scholar
• Nakaya N, Mizuno K, Ohashi Y, et al. Low-dose pravastatin and age related differences in risk factors for cardiovascular disease in hypercholesterolaemic Japanese: analysis of the management of elevated cholesterol in the primary prevention group of adult Japanese (MEGA study). Drugs Aging. 2011;28:681–692. doi:10.2165/11595620-000000000-0000021815708
   PubMed Web of Science ®Google Scholar
• Neil HA, DeMicco DA, Luo D; on behalf of the CARDS Study Investigators. Analysis of efficacy and safety in patients aged 65–75 years at randomization: collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care. 2006;29:2378–2384. doi:10.2337/dc06-087217065671
   PubMed Web of Science ®Google Scholar
• Collier DJ, Poulter NR, Dahlöf B; on behalf of the ASCOT Investigators. Impact of atorvastatin among older and younger patients in the anglo-scandinavian cardiac outcomes trial lipid-lowering arm. J Hypertens. 2011;9:592–599. doi:10.1097/HJH.0b013e328342c8f7
   Web of Science ®Google Scholar
• Schubert CM, Rogers NL, Remsberg KE, et al. Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. Int J Obes (Lond). 2006;30(2):251–260. doi:10.1038/sj.ijo.080312916247511
   PubMed Web of Science ®Google Scholar
• Kapur NK, Ashen D, Blumenthal RS. High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Vasc Health Risk Manag. 2008;4:39–57.18629371
   PubMedGoogle Scholar
• Cervelli T, Borghini A, Galli A, Andreassi MG. DNA damage and repair in atherosclerosis: current insights and future perspectives. Int J Mol Sci. 2012;13:16929–16944. doi:10.3390/ijms13121692923443128
   PubMed Web of Science ®Google Scholar
• Nitenberg A, Cosson E, Pham I. Postprandial endothelial dysfunction: role of glucose, lipids and insulin. Diabetes Metab. 2006;32(Spec No2):S28–S33. doi:10.1016/S1262-3636(06)70482-7
   Web of Science ®Google Scholar
• Karaouzene N, Merzouk H, Aribi M, et al. Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men. Nutr Metab Cardiovasc Dis. 2011;21(10):792–999. doi:10.1016/j.numecd.2010.02.00720554180
   PubMed Web of Science ®Google Scholar
• Maurya PK, Kumar P, Chandra P. Biomarkers of oxidative stress in erythrocytes as a function of human age. World J Methodol. 2015;5(4):216–222. doi:10.5662/wjm.v5.i4.21626713282
   PubMedGoogle Scholar
• Amir Aslani B, Ghobadi S. Studies on oxidants and antioxidants with a brief glance at their relevance to the immune system. Life Sci. 2016;146:163–173. doi:10.1016/j.lfs.2016.01.01426792059
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Matsui T, Nakamura K. Possible link of food-derived advanced glycation end products (AGEs) to the development of diabetes. Med Hypotheses. 2008;71(6):876–878. doi:10.1016/j.mehy.2008.07.03418783891
   PubMed Web of Science ®Google Scholar
• Sacks DB. Hemoglobin A1c in diabetes: panacea or pointless? Diabetes. 2013;62:41–43. doi:10.2337/db12-148523258914
   PubMed Web of Science ®Google Scholar
• True MW. Circulating biomarkers of glycemia in diabetes management and implications for personalized medicine. J Diabetes Sci Technol. 2009;3(4):743–747. doi:10.1177/19322968090030042120144323
   PubMedGoogle Scholar
• Andriollo-Sanchez M, Hininger-Favier I, Meunier N, et al. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur J Clin Nutr. 2005;59(Suppl 2):S58–S62. doi:10.1038/sj.ejcn.160230016254584
   PubMed Web of Science ®Google Scholar
• Buffenstein R, Edrey YH, Yang T, Mele J. The oxidative stress theory of aging: embattled or invincible? Insights from non-traditional model organisms. Age (Dordr). 2008;30(2–3):99–109. doi:10.1007/s11357-008-9058-z19424860
   PubMedGoogle Scholar
• Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4): 851–863. doi:10.5114/aoms.2016.58928
   Web of Science ®Google Scholar
• Xu L, Yi-Ru W, Li PC, Feng B. Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol. Lipids Health Dis. 2016;15:161. doi:10.1186/s12944-016-0334-027644038
   PubMed Web of Science ®Google Scholar
• Linnane AW, Kios M, Vitetta L. Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide. Biogerontology. 2007;8:445–467. doi:10.1007/s10522-007-9096-417415678
   PubMed Web of Science ®Google Scholar
• Santilli F, D’Ardes D, Davì G. Oxidative stress in chronic vascular disease: from prediction to prevention. Vascul Pharmacol. 2015;74:23–37. doi:10.1016/j.vph.2015.09.00326363473
   PubMed Web of Science ®Google Scholar
• O’Brien E, Asmar R, Beilin L, et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens. 2005;23:697–701. doi:10.1097/01.hjh.0000163132.84890.c415775768
   PubMed Web of Science ®Google Scholar
• Zdrojewski T, Jankowski P, Bandosz P, et al. Nowa wersja systemu oceny ryzyka sercowo- -naczyniowego i tablic SCORE dla populacji Polski. A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population. Kard Pol. 2015;73(10):958–961. doi:10.5603/KP.2015.0182
   Web of Science ®Google Scholar
• World Health Organization. Prevention of diabetes mellitus. Tech. Rep. 844. Geneva, Switzerland: World Health Organization; 1994.
   Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358. doi:10.1016/0003-2697(79)90738-336810
   PubMed Web of Science ®Google Scholar
• Upmeier E, Lavonius S, Heinonen P, et al. Longitudinal changes in serum lipids in older people the Turku elderly study 1991–2006. Age Ageing. 2011;40:280–283. doi:10.1093/ageing/afg18021252037
   PubMed Web of Science ®Google Scholar
• Walter M. Interrelationships among HDL metabolism, aging, and atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1244–1250. doi:10.1161/ATVBAHA.108.18143819667114
   PubMed Web of Science ®Google Scholar
• Schalk BW, Visser M, Deeg DJ, Lm B. Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age Ageing. 2004;33:266–272. doi:10.1093/ageing/afh07315082432
   PubMed Web of Science ®Google Scholar
• Rowiński R, Kozakiewicz M, Kędziora-Kornatowska K, Hubner-Wozniak E, Kedziora J. Markers of oxidative stress and erythrocyte antioxidant enzyme activity in older men and women with differing physical activity. Exp Gerontol. 2013;48(11):1141–1146. doi:10.1016/j.exger.2013.07.01023911531
   PubMed Web of Science ®Google Scholar
• Distelmaier K, Goliasch G. Gone with the age(DL): high -density lipoprotein in senescence. Pol Arch Med Wewn. 2016;126(10):727–728. doi:10.20452/pamw.359427872449
   PubMed Web of Science ®Google Scholar
• Folsom AR, Yatsuya H, Nettleton JA, Lutsey PL, Cushman M, Rosamond WD. Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. J Am Coll Cardiol. 2011;57(16):1690–1696. doi:10.1016/j.jacc.2010.11.04121492767
   PubMed Web of Science ®Google Scholar
• Dziegielewska-Gesiak S, Bielawska L, Zowczak-Drabarczyk M, et al. The impact of high density lipoprotein on oxidant-antioxidant balance in healthy elderly people. Pol Arch Med Wewn. 2016;126(10):731–738. doi:10.20452/pamw.355927650303
   PubMed Web of Science ®Google Scholar
• Rogulj D, El Aklouk I, Konjevoda P, et al. Age-dependent systemic DNA damage in early Type 2 diabetes mellitus. Acta Biochim Pol. 2017;64(2):233–238. doi:10.18388/abp.2016_131328350403
   PubMed Web of Science ®Google Scholar
• Malczyk E, Dzięgielewska-Gesiak S, Fatyga E, Ziółko E, Kokot T, Muc-Wierzgoń M. Body composition in healthy older persons: role of the ratio of extracellular/total body water. J Biol Regul Homeost Agents. 2016;30(6):447–452.
   Google Scholar
• Block G, Dietrich M, Norkus EP, Packer L. Oxidative stress in human populations In: Rg C, Rodriguez H, editors. Critical Reviews of Oxidative Stress and Aging. Advances in Basic Science, Diagnostics and Intervention. Vol. 2 Singapore: World Scientific Publishing; 2003:870–880.
   Google Scholar
• Moreto F, de Oliveira EP, Manda RM, Burini RC. The higher plasma malondialdehyde concentrations are determined by metabolic syndrome-related glucolipotoxicity. Oxid Med Cell Longev. 2014;Article ID 505368. doi:10.1155/2014/505368
   Web of Science ®Google Scholar
• Hadj Ahmed S, Kharroubi W, Kaoubaa N, et al. Correlation of trans fatty acids with the severity of coronary artery disease lesions. Lipids Health Dis. 2018;17:52. doi:10.1186/s12944-018-0699-329544473
   PubMed Web of Science ®Google Scholar
• Cherubini A, Zuliani G, Costantini F, et al. High vitamin E plasma levels and low density lipoprotein oxidation are associated with the absence of atherosclerosis in octogenarians. J Am Geriatr Soc. 2001;49:651–654. doi:10.1046/j.1532-5415.2001.49128.x11380761
   PubMed Web of Science ®Google Scholar
• Augusti PR, Ruviaro AR, Quatrin A, et al. Imbalance in superoxide dismutase/thioredoxin reductase activities in hypercholesterolemic subjects: relationship with low density lipoprotein oxidation. Lipids Health Dis. 2012;11:79. doi:10.1186/1476-511X-11-7922721254
   PubMed Web of Science ®Google Scholar
• Dubowitz N, Xue W, Long Q, et al. Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity. Diabet Med. 2014;31:927–935. doi:10.1111/dme.1245924698119
   PubMed Web of Science ®Google Scholar
• Sushma V, Nibha S, Pushpank V, Shukla KN, Mohammad A, Monisha B. Antioxidant enzyme levels as markers for type 2 diabetes mellitus. Int J Bioassays. 2013;2:685–690.
   Google Scholar
• Malmström H, Walldius G, Grill V, Jungner I, Hammar N. Fructosamine is a risk factor for myocardial infarction and all-cause mortality – longitudinal experience from the AMORIS cohort. Nutr Metab Cardiovasc Dis. 2015;25(10):943–950. doi:10.1016/j.numecd.2015.07.00226296867
   PubMed Web of Science ®Google Scholar
• Mazidi M, Mikhailidis DP, Banach M. Higher dietary acid load is associated with higher likelihood of peripheral arterial disease among American adults. J Diabetes Complications. 2018. doi:10.1016/j.jdiacomp.2018.03.001
   Web of Science ®Google Scholar